Steris (STE) Depreciation & Amortization (CF) (2018 - 2026)
Steris' (STE) quarterly Depreciation & Amortization (CF) came in at $123.4 million in Q1 2026, up 0.9% year-on-year from $122.3 million in Q1 2025, and up 1.15% quarter-over-quarter from $122.0 million in Q4 2025.
Steris (STE) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Steris' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $123.4 million for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 0.9% year-over-year to $123.4 million in Q1 2026; TTM through Mar 2026 was $486.5 million, a 2.16% increase from a year earlier, with the FY2026 full-year figure at $486.5 million, up 2.16% from the prior year.
- Depreciation & Amortization (CF) improved to $123.4 million in Q1 2026 per STE's latest filing, from $122.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $233.8 million in Q1 2022 and bottomed at $112.7 million in Q2 2024.
- The 5-year median for Depreciation & Amortization (CF) is $133.9 million (2022), against an average of $136.2 million.
- Across the five-year window, Depreciation & Amortization (CF) jumped 296.03% in 2022 and plunged 39.19% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $138.0 million in 2022, then gained by 1.94% to $140.6 million in 2023, then declined by 10.47% to $125.9 million in 2024, then declined by 3.1% to $122.0 million in 2025, then increased by 1.15% to $123.4 million in 2026.
- Per Business Quant, the three latest STE Depreciation & Amortization (CF) figures stand at $123.4 million (Q1 2026), $122.0 million (Q4 2025), and $121.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 123.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.40 Mn |
| Mar 31, 2026 | 123.40 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Dec 31, 2025 | 122.00 Mn |
| Sep 30, 2025 | 121.70 Mn |
| Sep 30, 2025 | 121.70 Mn |
| Jun 30, 2025 | 119.40 Mn |
| Jun 30, 2025 | 119.40 Mn |
| Mar 31, 2025 | 122.30 Mn |
| Mar 31, 2025 | 122.30 Mn |
| Dec 31, 2024 | 125.90 Mn |
| Dec 31, 2024 | 125.90 Mn |
| Sep 30, 2024 | 115.30 Mn |
| Sep 30, 2024 | 115.30 Mn |
| Jun 30, 2024 | 112.70 Mn |
| Jun 30, 2024 | 112.70 Mn |
| Mar 31, 2024 | 134.39 Mn |
| Mar 31, 2024 | 134.39 Mn |
| Dec 31, 2023 | 140.63 Mn |
| Dec 31, 2023 | 140.63 Mn |